Efficacy and Safety of Insulin Detemir Plus Insulin Aspart Versus NPH Insulin Plus Human Soluble Insulin with or Without Metformin in Chinese Type 2 Diabetes

郭晓蕙,李启富,石勇铨,卜瑞芳,刘精东,曲伸,高妍

DOI: https://doi.org/10.3969/j.issn.1006-6187.2014.01.010

2014-01-01

Abstract:Objective To investigate if insulin detemir+insulin aspart± metformin(insulin analogues group)is superior to NPH insulin+ human soluble insulin± metformin(human insulin group) with respect to glycaemic control in hospitalised Chinese T2DM patients uncontrolled with basal insulin once daily or premixed insulin twice daily with or without oral antidiabetic drugs.Methods Two groups were hospitalised and treated for two weeks to compare the efficacy and safety of the two regimens.Results The mean eight-point plasma glucose decreased than before treatment in two groups,and there was no significant difference of the change between two groups(P=0.9157).In two groups,the numbers of adverse events and incidences of hypoglycaemia were low.There were neither serious adverse events nor severe hypoglycaemic events reported.The rates of overall hypoglycaemia and daytime hypoglycaemia were significantly lower in insulin analogues group than in human insulin group(P=0.0056,0.0263).Conclusion Both insulin analogues combination and human insulin combination comparably improved glycaemic control in hospitalised T2DM patients.Moreover,the overall and diurnal hypoglycaemic risk in insulin analogues regimen was lower than that of the human insulin regimen.